ArticleFuture oncology (London, England)2024

An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: 'R-ISV-FOLactis' trial.

Juanjuan Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.